Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.46
Delayed Data
As of Aug 28
 +0.06 / +4.29%
Today’s Change
1.33
Today|||52-Week Range
3.00
-20.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash------55.2M
 
 
Short Term Investment Cash-8.9M25.0M34.4M-31.6M
 
 
 
 
 
Cash & Short Term Investments27.2M52.0M86.4M55.2M
 
 
 
 
 
 
ReceivablesReceivables4.8M1.4M2.1M1.9M
 
 
 
 
 
 
InventoriesInventories279.0K4.0M8.0M6.7M
 
 
 
 
 
 
Current AssetsPrepaid Expenses235.0K251.0K286.0K369.0K
 
 
 
 
 
Other Current Assets0.003.3M1.2M1.4M
 
 
 
 
Current Assets32.5M61.1M97.9M65.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross29.4M31.1M32.0M32.7M
 
 
 
 
 
Depreciation-11.1M-14.8M-18.3M-21.5M
 
 
 
 
 
Other Assets1.0M1.3M1.7M1.7M
 
 
 
 
 
Total Assets51.8M78.7M113.3M78.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.0M5.3M5.3M4.0M
 
 
 
 
 
Accrued Expenses3.9M6.2M4.9M12.8M
 
 
 
 
 
Other Current Liabilities11.3M18.7M19.9M21.0M
 
 
 
 
 
Other Liabilities18.7M25.8M26.7M26.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0067.0M67.5M
 
 
 
Other Liabilities6.6M5.4M2.4M912.0K
 
 
 
 
 
Total Liabilities77.9M82.1M140.3M134.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-26.1M-3.4M-26.9M-55.6M
 
 
 
 
 
Total Shareholder Equity-26.1M-3.4M-26.9M-55.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding85.6M93.5M93.6M93.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.